Olmer Ruth, Haase Alexandra, Merkert Sylvia, Cui Wei, Palecek Jirí, Ran Chen, Kirschning Andreas, Scheper Thomas, Glage Silke, Miller Konstantin, Curnow Eliza C, Hayes Eric S, Martin Ulrich
Leibniz Research Laboratories for Biotechnology and Artificial Organs (LEBAO), Department of Cardiac, Thoracic-, Transplantation and Vascular Surgery, Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hannover, Germany.
Stem Cell Res. 2010 Jul;5(1):51-64. doi: 10.1016/j.scr.2010.03.005. Epub 2010 Mar 30.
Therapeutic application of stem cell derivatives requires large quantities of cells produced in defined media that cannot be produced via conventional adherent culture. We have applied human induced pluripotent stem (hiPS) cells expressing eGFP under control of the OCT4 promoter to establish the expansion of undifferentiated human embryonic stem (hES) and hiPS cells in suspension culture. A defined culture medium has been identified that results in up to six-fold increase in cell numbers within four days. Our culture system is based on initial single cell dissociation which is critical for standardized process inoculation. HES / hiPS cells were expanded for up to 17 passages. The cells maintained a stable karyotype, their expression of pluripotency markers and their potential to differentiate into derivatives of all three germ layers. The ability to expand HES / hiPS cells in a scalable suspension culture represents a critical step towards standardized production in stirred bioreactors.
干细胞衍生物的治疗应用需要在特定培养基中大量生产细胞,而这无法通过传统的贴壁培养实现。我们应用了在OCT4启动子控制下表达eGFP的人诱导多能干细胞(hiPS),以在悬浮培养中实现未分化的人胚胎干细胞(hES)和hiPS细胞的扩增。已确定一种特定的培养基,可在四天内使细胞数量增加多达六倍。我们的培养系统基于最初的单细胞解离,这对于标准化的过程接种至关重要。HES/hiPS细胞扩增了多达17代。这些细胞保持了稳定的核型、多能性标志物的表达以及分化为所有三个胚层衍生物的潜力。在可扩展的悬浮培养中扩增HES/hiPS细胞的能力是朝着在搅拌生物反应器中进行标准化生产迈出的关键一步。